Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities



Rating:

Share or cite this content

Citations should be made in the following way:
A. Polyakova (Moscow, Russian Federation), M. Tihonova (Moscow, Russian Federation), V. Romanov (Moscow, Russian Federation), A. Tihonov (Moscow, Russian Federation), N. Chernyh (Moscow, Russian Federation). Mesodiencephalic modulation in the treatment of XDR TB patients with concomitant type II diabetes mellitus. 1035

Member's Comments

No comment yet.

Related content which might interest you: Effectiveness of mesodiencephalic modulation in treatment of XDR TB patients with concomitant type II diabetes mellitus Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019 Treatment effectiveness among patients with newly detected pulmonary tuberculosis with diabetes mellitus comorbidity Source: Eur Respir J 2004; 24: Suppl. 48, 653s Year: 2004 Presentations and treatment response of pulmonary tuberculosis in type 2 diabetes mellitus Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012 Is there any characteristics difference between pulmonary tuberculosis patients with and without diabetes mellitus type 2? Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities Year: 2009 Clinical manifestations and efficacy MDR/XDR tuberculosis in patients with different type’s of diabetes mellitus Source: International Congress 2015 – Case series and clinical conundrums in TB Year: 2015 Newly detected pulmonary tuberculosis in patients combined with diabetes mellitus and without it. Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019 Effectiveness of lung surgery in MDR TB patients with diabetes mellitus Source: International Congress 2016 – Open problems in thoracic surgery Year: 2016 The evaluation of tuberculosis risk in diabetes mellitus patients in a high incidence of tuberculosis region Source: Annual Congress 2010 - Tuberculosis: metabolic insights Year: 2010 Impact of diabetes mellitus on MDR-TB outcome Source: International Congress 2018 – Tuberculosis comorbidities Year: 2018 Role of BMI in the clinical course of COPD patients with type 2 diabetes mellitus Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Efficacy of treatment of MDR/XDR TB patients with diabetes mellitus Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 Clinical features of pulmonary tuberculosis in patients with diabetes mellitus Source: Annual Congress 2012 - Tuberculosis: clinical findings III Year: 2012 Comparison of the clinical manifestations of tuberculosis in patients with different type’s of diabetes mellitus and without it Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe Year: 2016 Prevalence and factors associated with diabetes mellitus among tuberculosis patients: a nationwide cohort Source: Eur Respir J 2016; 48: 264-268 Year: 2016 Outcomes among patients with pulmonary TB with diabetes mellitus treated with anti-TB drugs of 1st line Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities Year: 2010 Side effects of isoniazid and streptomycine in patients with pulmonary tuberculosis accompanying diabetes mellitus and diabetic foot syndrome Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III Year: 2008 Intensive chemotherapy of pulmonary tuberculosis in patients with diabetes mellitus Source: Eur Respir J 2004; 24: Suppl. 48, 648s Year: 2004 A study of the comorbidity of COPD and type 2 diabetes mellitus Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 The coexisting pulmonary tuberculosis and diabetes mellitus Source: Eur Respir J 2006; 28: Suppl. 50, 26s Year: 2006 Comparison of COPD patients with and without diabetes mellitus Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020